A Study of Nimotuzumab in Combination With Radiation Therapy in Patients With Brain Metastases
Status:
Terminated
Trial end date:
2011-07-01
Target enrollment:
Participant gender:
Summary
This is a randomized, Phase II study designed to investigate Nimotuzumab plus whole-brain
radiation therapy (WBRT)and to compare it rith WBRT alone in patients with brain metastases
from non-small cell lung cancer (NSCLC). The purpose of the study is to assess the efficacy
of nimotuzumab in combination with WBRT.